Tulavi Therapeutics

As 2024 comes to a close, we want to take a moment and celebrate what has been an incredible year for our patients, surgeon partners, and Tulavi. We could not be more excited about the future and our mission to transform peripheral nerve surgery.    Since receiving FDA clearance in late July for the groundbreaking allay™ Nerve Cap, we have hit the ground running. allay™ is the first and only fully absorbable in situ forming technology designed to protect transected nerves, block axonal escape, and reduce the risk of neuroma formation. Following our market debut this year at #ASSH we have already been adopted by some of the top academic medical centers and community hospitals across the country, taking us from a promising innovation to a transformative solution for peripheral nerve surgery.    Concurrent with our market clearance, Tulavi has expanded with incredible additions to our commercial, R&D, regulatory, and operations teams -- all to enable greater access to our products.   To our patients, surgeon partners, and the institutions who believe in us: Thank You! Your belief in our mission fuels our work every day.    Here's to the patients we serve, and the progress we'll continue to drive in peripheral nerve surgery. We wish all of you a wonderful 2025!

Come say Aloha and see the latest innovation in peripheral nerve surgery at the 2025 AAHS/ASPN/ASRM Annual Meetings where we will be showcasing the allay™ Nerve Cap - Booth #94.   📅 Exhibitor Dates: January 15-20, 2025  📍 Booth #94 ❔ Interested in learning more? Click here: https://shorturl.at/PYGDP #HandSurgery #PeripheralNerveSurgery #ReconstructiveMicrosurgery #AAHS2025 #ASPN2025 #ASRM2025 #Tulavi #nervecare #neuromaprevention American Society for Surgery of the Hand

Tulavi Therapeutics thanks the organizers at the American Society for Surgery of the Hand #ASSH24 for setting up an excellent conference and forum to discuss improvements in #handsurgery. We appreciated each conversation and are glad to support you in #advancing peripheral #nerve care. #Medicalinnovation

Exciting times at #ASSH24! The Tulavi team is thrilled to be here, showcasing our innovative allay™ Nerve Cap at Booth #208. The response has been incredible so far, and we're grateful for the chance to connect with so many industry leaders and professionals. Thank you to everyone who has stopped by to learn more about how allay is making a difference in peripheral nerve repair! #HandSurgery #MedicalInnovation #Tulavi #nervecare

Join Tulavi at the American Society for Surgery of the Hand (ASSH) 2024 Annual Meeting #ASSH24! We’ll be exhibiting at Booth #208, showcasing the latest innovation in peripheral nerve care.   Don't miss this opportunity to connect with our team, explore our cutting-edge technology, and learn how Tulavi is transforming patient care. We look forward to seeing you there! 📅 Date: Sept 19-21, 2024 📍 Booth #208 – ASSH 2024 #HandSurgery #MedicalInnovation #Tulavi #nervecare

We are proud to announce the allay™ Nerve Cap has received FDA De Novo Classification and clearance to market. This significant milestone underscores the importance of our technology in advancing peripheral nerve care. We are so proud of our team and the support of our investors for making this possible. With this achievement, we are excited to commence the Early Market Release for our initial cases. Learn more about the allay™ Nerve Cap at https://lnkd.in/gVUNHyE5